BMS-986231
BMS-986231 is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
4
Early Stage
1
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
100.0%
5 of 5 finished
0.0%
0 ended early
0
trials recruiting
5
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
An Investigational Study of Continuous 8-Hour Intravenous Administrations of BMS-986231 in Participants With Heart Failure and Reduced Heart Function Given a Standard Dose of Loop Diuretic
An Investigational Study of Experimental Medication BMS-986231 Given in Participants With Different Levels of Liver Function
A Study of Experimental Medication BMS-986231 in Patients With Different Levels of Kidney Function
Pharmacokinetics and Metabolism of [14C] BMS-986231 in Healthy Male Participants
Study With Healthy Japanese and Non-Asian Participants With BMS-986231
Clinical Trials (5)
An Investigational Study of Continuous 8-Hour Intravenous Administrations of BMS-986231 in Participants With Heart Failure and Reduced Heart Function Given a Standard Dose of Loop Diuretic
An Investigational Study of Experimental Medication BMS-986231 Given in Participants With Different Levels of Liver Function
A Study of Experimental Medication BMS-986231 in Patients With Different Levels of Kidney Function
Pharmacokinetics and Metabolism of [14C] BMS-986231 in Healthy Male Participants
Study With Healthy Japanese and Non-Asian Participants With BMS-986231
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5